VEIL.AI, the most experienced European health tech company in health data anonymization, has announced a new addition to their board of directors, Mr. Mikko Mannerkoski. With extensive experience as a founder of multiple biotech companies and a chairman, Mr. Mannerkoski has made significant contributions to the field of cancer treatment and pharmaceutical research. As the founder of Aventum Partners, Mr. Mannerkoski brings valuable expertise in corporate finance and advisory services. VEIL.AI is excited to welcome him as a new chairman of the board and looks forward to his insights and contributions.
By Tuomo Pentikäinen
June 5, 2023